Abstract

Conventional cervical cancer prevention program has prevented majority of cervical cancers in developed countries. The laboratory test to identify molecular markers for cervical precancerous lesion is a new direction with a lower cost, which will benefit the underdeveloped countries. Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3 or IMP3) has demonstrated to be a marker positive for cervical intraepithelial lesions that lead to invasive cervical cancers. This study is to develop a real-time PCR method for detection for IGF2BP3, which is relevant to squamous intraepithelial lesions. Pap smear cervical cells in methanol-based preservatives were collected after cytopathologic diagnosis (ie, 8 specimens with negative findings, 8 specimens with ASCUS, 8 specimens with LGSIL, and 7 specimens with HGSIL). Total RNA was extracted from the preserved cells with regular Trizol method and cDNA was synthesized by reverse transcriptase. Real-time PCR (RT-PCR) experiments were performed with SYBR Green Supermix. RNA extraction from methanol-based preservatives is successful. The expression of IGF2BP3 is detectable in both normal and abnormal cervical cells, with the high-grade squamous intraepithelial lesional cells ~10 times of those normal cervical cells (P = .004). In this study, the ASCUS group has similar IGF2BP3 gene expression as in normal cervical cells, while the LGSIL cells have a variable IGF2BP3 gene expression and an average ~6 times of those in normal cervical cells (P > .05). High expression of IGF2BP3 is indicative of high-grade dysplasia with a sensitivity of 85.7% and a specificity of close to 67% compared with low-grade lesions. Real-time PCR is a reliable method to determine IGF2BP3 mRNA in methanol-based fixed cervical cells. IGF2BP3 may serve as an ancillary or an independent biomarker for high-grade lesions in future cervical screening. To be confirmative, future studies with a large number of cases are required.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.